6533b85dfe1ef96bd12be644

RESEARCH PRODUCT

Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database

Nicolaus SchwerkJens GottliebMurielle VerboomBernhard GohrbandtAxel HaverichMurat AvsarThierry SiemeniWiebke SommerC. ErdfelderIgor TudoracheJawad SalmanGregor WarneckeM. Mehwald-goekeMark GreerDietmar BoethigChristian KuehnFabio IusTobias Welte

subject

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSurgerySingle centresurgical procedures operativePlatelet transfusionCryoprecipitatemedicineLung transplantationSurgeryFresh frozen plasmaCardiology and Cardiovascular MedicinebusinessIntensive care medicine

description

s S233 218 (82%) patients received pooled platelet transfusion -median (IQR) 1(1-2) U. 209 (79%) and 129 (49%) patients received fresh frozen plasma (FFP) and cryoprecipitate with a median (IQR) of 3(2-4) and 0(0-0) U respectively. Conclusion: Rate and volume of transfusion of blood products compare favourably with centres performing surgery off CPB or on ECMO. Requirement for ECMO particularly for BTT, but also PGD is associated with high transfusion requirements.

yearjournalcountryeditionlanguage
2016-04-01The Journal of Heart and Lung Transplantation
https://doi.org/10.1016/j.healun.2016.01.663